We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Malignant cells generally displayed moderate to strong cytoplasmic immunoreactivity with a granular pattern. Strongest immunoreactivity was observed in liver cancers.
A majority of malignant lymphomas, thyroid, liver and renal cancers exhibited strong cytoplasmic immunoreactivity. Remaining cancers generally displayed weak to moderate cytoplasmic staining.
GENE INFORMATION
Gene name
ACADM (HGNC Symbol)
Synonyms
ACAD1, MCAD, MCADH
Description
Acyl-CoA dehydrogenase, C-4 to C-12 straight chain (HGNC Symbol)
Entrez gene summary
This gene encodes the medium-chain specific (C4 to C12 straight chain) acyl-Coenzyme A dehydrogenase. The homotetramer enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Defects in this gene cause medium-chain acyl-CoA dehydrogenase deficiency, a disease characterized by hepatic dysfunction, fasting hypoglycemia, and encephalopathy, which can result in infantile death. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
P11310 [Direct mapping] Medium-chain specific acyl-CoA dehydrogenase, mitochondrial
Show all
Enzymes ENZYME proteins Oxidoreductases SPOCTOPUS predicted membrane proteins Predicted intracellular proteins Disease related genes Potential drug targets Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000062 [fatty-acyl-CoA binding] GO:0003995 [acyl-CoA dehydrogenase activity] GO:0005634 [nucleus] GO:0005739 [mitochondrion] GO:0005759 [mitochondrial matrix] GO:0006635 [fatty acid beta-oxidation] GO:0008152 [metabolic process] GO:0009055 [electron carrier activity] GO:0016627 [oxidoreductase activity, acting on the CH-CH group of donors] GO:0019254 [carnitine metabolic process, CoA-linked] GO:0030424 [axon] GO:0033539 [fatty acid beta-oxidation using acyl-CoA dehydrogenase] GO:0042802 [identical protein binding] GO:0044255 [cellular lipid metabolic process] GO:0044281 [small molecule metabolic process] GO:0045329 [carnitine biosynthetic process] GO:0050660 [flavin adenine dinucleotide binding] GO:0051791 [medium-chain fatty acid metabolic process] GO:0051793 [medium-chain fatty acid catabolic process] GO:0052890 [oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor] GO:0055088 [lipid homeostasis] GO:0055114 [oxidation-reduction process] GO:0070062 [extracellular exosome] GO:0070991 [medium-chain-acyl-CoA dehydrogenase activity]
P11310 [Direct mapping] Medium-chain specific acyl-CoA dehydrogenase, mitochondrial
Show all
Enzymes ENZYME proteins Oxidoreductases SPOCTOPUS predicted membrane proteins Predicted intracellular proteins Disease related genes Potential drug targets Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
Show all
GO:0000062 [fatty-acyl-CoA binding] GO:0003995 [acyl-CoA dehydrogenase activity] GO:0005634 [nucleus] GO:0005739 [mitochondrion] GO:0005759 [mitochondrial matrix] GO:0006635 [fatty acid beta-oxidation] GO:0008152 [metabolic process] GO:0009055 [electron carrier activity] GO:0016627 [oxidoreductase activity, acting on the CH-CH group of donors] GO:0019254 [carnitine metabolic process, CoA-linked] GO:0030424 [axon] GO:0033539 [fatty acid beta-oxidation using acyl-CoA dehydrogenase] GO:0042802 [identical protein binding] GO:0044255 [cellular lipid metabolic process] GO:0044281 [small molecule metabolic process] GO:0045329 [carnitine biosynthetic process] GO:0050660 [flavin adenine dinucleotide binding] GO:0051791 [medium-chain fatty acid metabolic process] GO:0051793 [medium-chain fatty acid catabolic process] GO:0052890 [oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor] GO:0055088 [lipid homeostasis] GO:0055114 [oxidation-reduction process] GO:0070062 [extracellular exosome] GO:0070991 [medium-chain-acyl-CoA dehydrogenase activity]